S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NVIV InVivo Therapeutics Holdings Corporation

0.3207

0.00 (0.00%)

Last Updated: 11:00:00

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more InVivo Therapeutics Charts.

InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more InVivo Therapeutics Charts.

InVivo Therapeutics Holdings Corporation News

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Friday 22 March 2024 (8 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (9 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Thursday 8 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 8 February 2024 (9 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 7 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 2 February 2024 (10 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Wednesday 6 December 2023 (12 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 2 December 2023 (12 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 December 2023 (12 months ago) • Edgar (US Regulatory)

More InVivo Therapeutics Holdings Corporation News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions